Editorials
Flawed evidence underpins approval of new cancer drugs
BMJ 2019; 366 doi: https://doi.org/10.1136/bmj.l5399 (Published 18 September 2019) Cite this as: BMJ 2019;366:l5399Linked Research
Design characteristics, risk of bias, and reporting of RCTs supporting approvals of cancer drugs by EMA
Linked Opinion
Gauging the validity of cancer drug trials: a call for collaboration
Article usage
Article metrics provide readers and authors with an indication of how often a specific article has been accessed month by month. It counts three formats - abstract/extract, full text and pdf. The page is updated each day.